Fish as models to study liver and blood lipid-related effects of fibrates and statins and screen new hypolipidemic drugs
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · 2023
DOI: 10.1016/j.cbpc.2023.109756 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2023. Verfasst von Tiago Lourenço und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Histology and Embryology, Department of Microscopy, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Por…. Hauptthemen laut MEDLINE: Fibric Acids, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Liver, Hypolipidemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Fibrates and statins lead worldwide prescriptions of lipid-lowering drugs, whose consumption is increasing considerably due to the growing incidence of dyslipidemias, particularly in high-income areas. Consequently, these chemicals are frequently found in aquatic environments, usually closer to highly urbanized and populated areas, reaching the water systems primarily through waste-water treatment plant (WWTP) effluents. Despite that, the knowledge regarding the effects caused by fibrates and statins in fish, namely in liver lipid metabolism and blood-related parameters, is still very limited. There is yet no standardized fish model for testing the effects of those drugs. However, experimental evidence suggests that the mechanisms of action (MoA) of fibrates and statins are fairly similar to those observed in humans, which makes these aquatic organisms viable alternatives for toxicological and mechanistic studies. This graphical review serves as a state point regarding the potential use of fish as a model for the study of hypolipidemic compounds, addressing (I) the current state of aquatic pollution caused by statins and fibrates, (II) the experimental designs used in the literature to assess effects on fish, (III) the liver metabolism and blood effects caused by exposure to fibrates and statins, as well as (IV) the MoA of both drugs. It further focuses on the current and future benefits of establishing a standardized fish model(s) for testing hypolipidemic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Histology and Embryology, Department of Microscopy, ICBAS - School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal; Team of Animal Morphology and Toxicology, CIIMAR/CIMAR - Interd…
Zitieren
APA
Lourenço, T., Madureira, T. V., Rocha, M. J., & Rocha, E. (2023). Fish as models to study liver and blood lipid-related effects of fibrates and statins and screen new hypolipidemic drugs. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. https://doi.org/10.1016/j.cbpc.2023.109756
Vancouver
Lourenço T, Madureira TV, Rocha MJ, Rocha E. Fish as models to study liver and blood lipid-related effects of fibrates and statins and screen new hypolipidemic drugs. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2023. doi:10.1016/j.cbpc.2023.109756
BibTeX
@article{Loureno2023,
author = {Lourenço, Tiago and Madureira, Tânia Vieira and Rocha, Maria João and Rocha, Eduardo},
title = {Fish as models to study liver and blood lipid-related effects of fibrates and statins and screen new hypolipidemic drugs},
journal = {Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology},
year = {2023},
doi = {10.1016/j.cbpc.2023.109756}
}
EUVIMED